Torso Hemorrhage Kills 85-100% Because No Tourniquet Can Reach It
defense+2defensehealthcaretechnology0 views
Standard tourniquets -- the single most effective prehospital intervention in the last two decades of war -- only work on extremities. Non-compressible torso hemorrhage (NCTH) from shrapnel, blast fragments, and gunshot wounds to the abdomen, pelvis, and junctional zones (groin, axilla, neck) cannot be controlled with a Combat Application Tourniquet. NCTH is now the leading cause of preventable battlefield death, with mortality rates between 85% and 100% when evacuation is delayed.
This matters because in large-scale combat operations against a near-peer adversary, air superiority will not be guaranteed, and evacuation timelines will stretch from the current 60-minute 'golden hour' standard to hours or even days. Every minute a junctional or torso bleed goes uncontrolled, the casualty's survival probability drops. The devices that do exist -- the Abdominal Aortic and Junctional Tourniquet (AAJT-S), SAM Junctional Tourniquet, REBOA catheters, and XStat wound-packing sponges -- are either too bulky to carry in a standard IFAK, require advanced training to apply, or are not yet widely fielded to line units.
The structural reason this persists is the physics of the problem: you cannot externally compress a bleeding vessel inside the torso the way you can compress a femoral artery against a femur. Every solution requires either invasive access (REBOA), specialized hardware (junctional tourniquets weigh 1-2 lbs each), or surgical intervention. The military procurement cycle is slow -- the AAJT-S has proven efficacy in studies published in the Journal of Special Operations Medicine but is still not standard-issue in most infantry platoons. Until a lightweight, idiot-proof device for NCTH control exists in every rifleman's kit, the number-one killer on the battlefield will remain the one wound nobody at point of injury can treat.
Evidence
NCTH accounts for the majority of preventable combat deaths. Compression Works published peer-reviewed results in the Journal of Special Operations Medicine confirming AAJT-S controls NCTH (https://compressionworks.com/newsroom/study-confirms-aajt-s-controls-non-compressible-torso-hemorrhage-top-cause-of-battlefield-deaths). FDA has cleared junctional tourniquets and XStat for clinical use, but they are not yet standard-issue across conventional infantry. European Journal of Medical Research, March 2024: 'Torso hemorrhage: noncompressible? never say never' (https://eurjmedres.biomedcentral.com/articles/10.1186/s40001-024-01760-4).